Implantable Cardioverter Defibrillator (ICD) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) INDUSTRY

2.1 Summary about Implantable Cardioverter Defibrillator (ICD) Industry

2.2 Implantable Cardioverter Defibrillator (ICD) Market Trends

2.2.1 Implantable Cardioverter Defibrillator (ICD) Production & Consumption Trends

2.2.2 Implantable Cardioverter Defibrillator (ICD) Demand Structure Trends

2.3 Implantable Cardioverter Defibrillator (ICD) Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 By Products Type

4.2.2 Single Chamber ICD

4.2.3 Dual Chamber ICD

4.2.4 Biventricular ICD

4.2.5 By Implantation Site

4.2.6 Transvenous ICD

4.2.7 Subcutaneous ICD

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Bradycardia

4.3.2 Tachycardia

4.3.3 Heart Failure

4.3.4 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 By Products Type

5.2.2 Single Chamber ICD

5.2.3 Dual Chamber ICD

5.2.4 Biventricular ICD

5.2.5 By Implantation Site

5.2.6 Transvenous ICD

5.2.7 Subcutaneous ICD

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Bradycardia

5.3.2 Tachycardia

5.3.3 Heart Failure

5.3.4 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 By Products Type

6.2.2 Single Chamber ICD

6.2.3 Dual Chamber ICD

6.2.4 Biventricular ICD

6.2.5 By Implantation Site

6.2.6 Transvenous ICD

6.2.7 Subcutaneous ICD

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Bradycardia

6.3.2 Tachycardia

6.3.3 Heart Failure

6.3.4 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 By Products Type

7.2.2 Single Chamber ICD

7.2.3 Dual Chamber ICD

7.2.4 Biventricular ICD

7.2.5 By Implantation Site

7.2.6 Transvenous ICD

7.2.7 Subcutaneous ICD

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Bradycardia

7.3.2 Tachycardia

7.3.3 Heart Failure

7.3.4 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 By Products Type

8.2.2 Single Chamber ICD

8.2.3 Dual Chamber ICD

8.2.4 Biventricular ICD

8.2.5 By Implantation Site

8.2.6 Transvenous ICD

8.2.7 Subcutaneous ICD

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Bradycardia

8.3.2 Tachycardia

8.3.3 Heart Failure

8.3.4 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 By Products Type

9.2.2 Single Chamber ICD

9.2.3 Dual Chamber ICD

9.2.4 Biventricular ICD

9.2.5 By Implantation Site

9.2.6 Transvenous ICD

9.2.7 Subcutaneous ICD

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Bradycardia

9.3.2 Tachycardia

9.3.3 Heart Failure

9.3.4 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Medtronic

10.1.2 St. Jude Medical

10.1.3 Boston Scientific

10.1.4 Philips Healthcare

10.1.5 Zoll Medical

10.1.6 Biotronik Se

10.1.7 Physio-Control International

10.1.8 Cardiac Science

10.1.9 Sorin Group

10.1.10 Nihon Kohden

10.1.11 Shree Pacetronix Ltd.

10.1.12 EBR Systems

10.1.13 MEDICO S.p.A.

10.2 Implantable Cardioverter Defibrillator (ICD) Sales Date of Major Players (2017-2020e)

10.2.1 Medtronic

10.2.2 St. Jude Medical

10.2.3 Boston Scientific

10.2.4 Philips Healthcare

10.2.5 Zoll Medical

10.2.6 Biotronik Se

10.2.7 Physio-Control International

10.2.8 Cardiac Science

10.2.9 Sorin Group

10.2.10 Nihon Kohden

10.2.11 Shree Pacetronix Ltd.

10.2.12 EBR Systems

10.2.13 MEDICO S.p.A.

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Implantable Cardioverter Defibrillator (ICD) Product Type Overview

2.Table Implantable Cardioverter Defibrillator (ICD) Product Type Market Share List

3.Table Implantable Cardioverter Defibrillator (ICD) Product Type of Major Players

4.Table Brief Introduction of Medtronic

5.Table Brief Introduction of St. Jude Medical

6.Table Brief Introduction of Boston Scientific

7.Table Brief Introduction of Philips Healthcare

8.Table Brief Introduction of Zoll Medical

9.Table Brief Introduction of Biotronik Se

10.Table Brief Introduction of Physio-Control International

11.Table Brief Introduction of Cardiac Science

12.Table Brief Introduction of Sorin Group

13.Table Brief Introduction of Nihon Kohden

14.Table Brief Introduction of Shree Pacetronix Ltd.

15.Table Brief Introduction of EBR Systems

16.Table Brief Introduction of MEDICO S.p.A.

17.Table Products & Services of Medtronic

18.Table Products & Services of St. Jude Medical

19.Table Products & Services of Boston Scientific

20.Table Products & Services of Philips Healthcare

21.Table Products & Services of Zoll Medical

22.Table Products & Services of Biotronik Se

23.Table Products & Services of Physio-Control International

24.Table Products & Services of Cardiac Science

25.Table Products & Services of Sorin Group

26.Table Products & Services of Nihon Kohden

27.Table Products & Services of Shree Pacetronix Ltd.

28.Table Products & Services of EBR Systems

29.Table Products & Services of MEDICO S.p.A.

30.Table Market Distribution of Major Players

31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

33.Table Global Implantable Cardioverter Defibrillator (ICD) Market Forecast (Million USD) by Region 2021f-2026f

34.Table Global Implantable Cardioverter Defibrillator (ICD) Market Forecast (Million USD) Share by Region 2021f-2026f

35.Table Global Implantable Cardioverter Defibrillator (ICD) Market Forecast (Million USD) by Demand 2021f-2026f

36.Table Global Implantable Cardioverter Defibrillator (ICD) Market Forecast (Million USD) Share by Demand 2021f-2026f